138 related articles for article (PubMed ID: 7624919)
1. Bayesian forecasting of serum vancomycin concentrations in neonates and infants.
Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
Ther Drug Monit; 1995 Jun; 17(3):239-46. PubMed ID: 7624919
[TBL] [Abstract][Full Text] [Related]
2. Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model.
Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
Dev Pharmacol Ther; 1993; 20(3-4):211-9. PubMed ID: 7828456
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic parameters of vancomycin in critically ill patients.
Llopis-Salvia P; Jiménez-Torres NV
J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.
Rodvold KA; Pryka RD; Garrison M; Rotschafer JC
Ther Drug Monit; 1989; 11(3):269-75. PubMed ID: 2728085
[TBL] [Abstract][Full Text] [Related]
5. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
[TBL] [Abstract][Full Text] [Related]
7. Computer dosing program for the initiation of vancomycin therapy.
Ito MK; Duren LL; Simonian JS; Dreyfus-Vigil SD; Cookson TL
Clin Pharm; 1993 Feb; 12(2):126-30. PubMed ID: 8453861
[TBL] [Abstract][Full Text] [Related]
8. Predictive performance of a vancomycin-aminoglycoside population model.
Beringer PM; Wong-Beringer A; Rho JP
Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
Garrelts JC; Godley PJ; Horton MW; Karboski JA
Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
[TBL] [Abstract][Full Text] [Related]
10. Bayesian forecasting of gentamicin pharmacokinetics in pediatric intensive care unit patients.
Kraus DM; Dusik CM; Rodvold KA; Campbell MM; Kecskes SA
Pediatr Infect Dis J; 1993 Sep; 12(9):713-8. PubMed ID: 8414796
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.
Marqués-Miñana MR; Saadeddin A; Peris JE
Br J Clin Pharmacol; 2010 Nov; 70(5):713-20. PubMed ID: 21039765
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin monitoring: one or two serum levels?
Andrés I; López R; Pou L; Piñol F; Pascual C
Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Bayesian method for predicting vancomycin dosing.
Burton ME; Gentle DL; Vasko MR
DICP; 1989 Apr; 23(4):294-300. PubMed ID: 2728513
[TBL] [Abstract][Full Text] [Related]
15. Bayesian forecasting of serum vancomycin concentrations with non-steady-state sampling strategies.
Rodvold KA; Rotschafer JC; Gilliland SS; Guay DR; Vance-Bryan K
Ther Drug Monit; 1994 Feb; 16(1):37-41. PubMed ID: 8160252
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
Kimura T; Sunakawa K; Matsuura N; Kubo H; Shimada S; Yago K
Antimicrob Agents Chemother; 2004 Apr; 48(4):1159-67. PubMed ID: 15047516
[TBL] [Abstract][Full Text] [Related]
17. The characteristics and impact indicator of vancomycin pharmacokinetics in cancer patients complicated with severe pneumonia.
Zhang X; Wang D
J Infect Chemother; 2020 May; 26(5):492-497. PubMed ID: 31983615
[TBL] [Abstract][Full Text] [Related]
18. Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.
Pryka RD; Rodvold KA; Garrison M; Rotschafer JC
Ther Drug Monit; 1989; 11(4):450-4. PubMed ID: 2741194
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravenous rifampicin (rifampin) in neonates.
Pullen J; Stolk LM; Degraeuwe PL; van Tiel FH; Neef C; Zimmermann LJ
Ther Drug Monit; 2006 Oct; 28(5):654-61. PubMed ID: 17038881
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of predictability for vancomycin dosage regimens by the Bayesian method with Japanese population pharmacokinetic parameters.
Teramachi H; Hatakeyama H; Matsushita R; Imai Y; Miyamoto K; Tsuji A
Biol Pharm Bull; 2002 Oct; 25(10):1333-8. PubMed ID: 12392090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]